“…Over the last years, our group has been working on the development and synthesis of new quinoxaline derivatives. As a result of this line of research, the activities of quinoxaline 1,4-di- N -oxide derivatives against Mycobacterium tuberculosis [6,7,8,9,10,11,12,13], Trypanosoma cruzi [14,15], Leishmania amazonensis [16], L. infantum [17], P. falciparum [16,17,18,19,20,21,22,23] and different tumor cells [24,25,26] have been reported. The presence of two N -oxides is associated with a significant increase in some biological properties, such as anticancer [27] or antioxidant [28] activity.…”